Skip to Main Content

Paper Details

Dapagliflozin in Heart Failure With Mildly Reduced or Preserved Ejection Fraction According to Polypharmacy Status.
JACC Heart Fail
5
2023
Dapagliflozin, HF, Heart Failure, Patients, cardiovascular, cardiovascular death, dapagliflozin, heart failure, multimorbidity, participants, patients, vitamins
Author NameAffiliation
Mikhail KosiborodSaint Luke's Mid America Heart Institute, University of Missouri-Kansas City
Akshay S DesaiBrigham and Women's Hospital, Harvard Medical School
Carolyn S P LamNational Heart Centre Singapore and Duke-National University of Singapore, Singapore University of Groningen, University Medical Center Groningen
Rudolf A de Boer
Adrian F HernandezDuke University Medical Center
  • 1 - 5

Datasets

Release 1.2